Author:
Heaton Keith M.,Grimm Elizabeth A.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference81 articles.
1. Abbruzzese JL, Levin B, Ajani JA (1989) Phase I trial of recombinant human ?-IFN and recombinant human TNF in patients with advanced gastrointestinal cancer. Cancer Res 49: 4057
2. Arinaga S, Karimine N, Takamuku K, Nanbura S, Inoue H, Abe R (1992) Correlation of eosinophilia with clinical response in patients with advanced carcinoma treated with low dose recombinant IL-2 and mitomycin C. Cancer Immunol Immunother 35: 246
3. Budd GT, Osgood B, Barnes B, Botett JM, Finke J, Medendorp SV (1989) Phase I clinical trial of IL-2 and ?-IFN:, toxicity and immunologic effects. Cancer Res 49: 6432
4. Bukowski RM, Sergi JS, Budd GT, Murthy S, Tubbs R, Gibson V (1991) Phase I trial of continuous infusion IL-2 and doxorubicin in patients with refractory malignancies. J Immunother 10: 432
5. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin induced serum factor which causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献